[1] CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al. Sarcopenia: revised European consensus on definition and diagnosis [J]. Age Ageing, 2019, 48(1): 16-31. [2] CRUZ-JENTOFT A J, BAEYENS J P, BAUER J M, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People [J]. Age Ageing, 2010, 39(4): 412-423. [3] YANG L, YAO X, SHEN J, et al. Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents [J]. Exp Gerontol, 2020, 130: 110798. [4] CHEN L K, WOO J, ASSANTACHAI P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment [J]. J Am Med Dir Assoc, 2020, 21(3): 300-307 . [5] CHEN Z, LI W Y, HO M, et al. The prevalence of sarcopenia in Chinese older adults: meta-analysis and meta-regression [J]. Nutrients, 2021, 13(5) :1441. [6] LANDI F, CALVANI R, TOSATO M, et al. Protein intake and muscle health in old age: from biological plausibility to clinical evidence [J]. Nutrients, 2016, 8(5) :295. [7] VIDONI M L, PETTEE GABRIEL K, LUO S T, et al. Relationship between homocysteine and muscle strength decline: The Baltimore Longitudinal Study of Aging [J]. J Gerontol A Biol Sci Med Sci, 2018, 73(4): 546-551. [8] BLOM H J, SMULDERS Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects [J]. J Inherit Metab Dis, 2011, 34(1): 75-81. [9] KIM J, KIM H, ROH H, et al. Causes of hyperhomocysteinemia and its pathological significance [J]. Arch Pharm Res, 2018, 41(4): 372-383. [10] SHARMA G S, KUMAR T, SINGH L R. N-homocysteinylation induces different structural and functional consequences on acidic and basic proteins [J]. PLoS One, 2014, 9(12): e116386. [11] CLEOPHAS T J, HORNSTRA N, VAN HOOGSTRATEN B, et al. Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis [J]. Am J Cardiol, 2000, 86(9): 1005-1009. [12] WIERZBICKI A S. Homocysteine and cardiovascular disease: a review of the evidence [J]. Diab Vasc Dis Res, 2007, 4(2): 143-150. [13] HUMPHREY L L, FU R, ROGERS K, et al. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis [J]. Mayo Clin Proc, 2008, 83(11): 1203-1212. [14] 吴畅, 杜萱, 沈倍倍. 高胱氨酸血症与临床疾病 [J]. 实用老年医学, 1999, 13(3): 150-151. [15] CHOI J H, SEO J W, LEE M Y, et al. Association between elevated plasma homocysteine and low skeletal muscle mass in asymptomatic adults [J]. Endocrinol Metab: Seoul, 2022, 37(2): 333-343. [16] WANG C S, WONG T C, DUONG T V, et al. Hyperhomocysteinemia associated with low muscle mass, muscle function in elderly hemodialysis patients: an analysis of multiple dialysis centers [J]. Biomed Res Int, 2019, 2019: 9276097. [17] MCDERMOTT M M, FERRUCCI L, GURALNIK J M, et al. Elevated levels of inflammation, D-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease [J]. J Am Coll Cardiol, 2007, 50(9): 897-905. [18] SWART K M, ENNEMAN A W, VAN WIJNGAARDEN J P, et al. Homocysteine and the methylenetetrahydrofolate reductase 677C-->T polymorphism in relation to muscle mass and strength, physical performance and postural sway [J]. Eur J Clin Nutr, 2013, 67(7): 743-748. [19] GRANIC A, DAVIES K, MARTIN-RUIZ C, et al. Grip strength and inflammatory biomarker profiles in very old adults [J]. Age Ageing, 2017, 46(6): 976-982. [20] SOUMARÉ A, ELBAZ A, DUCROS V, et al. Cross-sectional association between homocysteine and motor function in the elderly [J]. Neurology, 2006, 67(6): 985-990. [21] GERDHEM P, IVASKA K K, ISAKSSON A, et al. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women [J]. J Bone Miner Res, 2007, 22(1): 127-134. [22] VIDONI M L, PETTEE GABRIEL K, LUO S T, et al. Vitamin B12 and homocysteine associations with gait speed in older adults: the Baltimore Longitudinal Study of Aging [J]. J Nutr Health Aging, 2017, 21(10): 1321-1328. [23] VAN SCHOOR N M, SWART K M, PLUIJM S M, et al. Cross-sectional and longitudinal association between homocysteine, vitamin B12 and physical performance in older persons [J]. Eur J Clin Nutr, 2012, 66(2): 174-181. [24] LU B, SHEN L, ZHU H, et al. Association between serum homocysteine and sarcopenia among hospitalized older Chinese adults: a cross-sectional study [J]. BMC Geriatr, 2022, 22(1): 896. [25] LEE W J, PENG L N, LOH C H, et al. Sex-different associations between serum homocysteine, high-sensitivity C-reactive protein and sarcopenia: results from I-Lan Longitudinal Aging Study [J]. Exp Gerontol, 2020, 132: 110832. [26] EGUCHI Y, TOYOGUCHI T, INAGE K, et al. Advanced glycation end products are associated with sarcopenia in older women: aging marker dynamics [J]. J Women Aging, 2021, 33(3): 328-340. [27] MAJUMDER A, SINGH M, BEHERA J, et al. Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury [J]. Am J Physiol Cell Physiol, 2018, 315(5): C609-C622. [28] YAKOVLEVA O V, ZIGANSHINA A R, DMITRIEVA S A, et al. Hydrogen sulfide ameliorates developmental impairments of rat offspring with prenatal hyperhomocysteinemia [J]. Oxid Med Cell Longev, 2018, 2018: 2746873. [29] VEERANKI S, LOMINADZE D, TYAGI S C. Hyperhomocysteinemia inhibits satellite cell regenerative capacity through p38 alpha/beta MAPK signaling [J]. Am J Physiol Heart Circ Physiol, 2015, 309(2): 325-334. [30] CHEN H, VERMULST M, WANG Y E, et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations [J]. Cell, 2010, 141(2): 280-289. [31] VEERANKI S, WINCHESTER L J, TYAGI S C. Hyperhomocysteinemia associated skeletal muscle weakness involves mitochondrial dysfunction and epigenetic modifications [J]. Biochim Biophys Acta, 2015, 1852(5): 732-741. [32] WINCHESTER L J, VEERANKI S, PUSHPAKUMAR S, et al. Exercise mitigates the effects of hyperhomocysteinemia on adverse muscle remodeling [J]. Physiol Rep, 2018, 6(6): e13637. [33] GIVVIMANI S, NARAYANAN N, ARMAGHAN F, et al. Attenuation of conducted vasodilation in skeletal muscle arterioles during hyperhomocysteinemia [J]. Pharmacology, 2013, 91(5/6): 287-296. [34] LI Z B, KOLLIAS H D, WAGNER K R. Myostatin directly regulates skeletal muscle fibrosis [J]. J Biol Chem, 2008, 283(28): 19371-19378. [35] ATES BULUT E, SOYSAL P, AYDIN A E, et al. Vitamin B12 deficiency might be related to sarcopenia in older adults [J]. Exp Gerontol, 2017, 95: 136-140. [36] KUO H K, LIAO K C, LEVEILLE S G, et al. Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults [J]. J Gerontol A Biol Sci Med Sci, 2007, 62(4): 434-439. [37] LEISHEAR K, FERRUCCI L, LAURETANI F, et al. Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs [J]. J Gerontol A Biol Sci Med Sci, 2012, 67(5): 537-543. |